Israeli investment firm eHealth Ventures (eHV) has announced the establishment of a $30 million venture capital fund for med tech and digital health companies, with the aim of raising $40 million.
The fund, called ‘eHV Advanced’, will focus on Israeli early-stage companies at seed stage, with a focus on diagnostics, digital monitoring, digital treatments, home care and bio-convergence. It will...
European digital health coaching company, Liva Healthcare and global biotechnology organisation, Amgen, have announced a partnership to make cardiac rehabilitation accessible to patients following a heart attack.
The collaboration will enable the companies to develop Rehab+, a digital tele-rehabilitation solution that allows patients to assess their lifestyle post-heart attack.
The new platform...
This morning Deloitte launched ConvergeHEALTH Connect, a new suite of four new healthcare products targeting a range of concentrations from public health care to personalized care, all of which runs on the Salesforce Health Cloud.
The full list includes tools for patient engagement, public health programs, providers and payers.
The first tool specifically aims to help life science companies...
Helsinki-based health data science company Kaiku Health, which offers digital patient monitoring and patient-reported outcome services, has announced that is teaming up with Amgen to roll out digital symptom tracking for multiple myeloma, a type of bone marrow cancer.
In collaboration with Turku University Hospital’s hematology unit in Finland, Kaiku Health developed in 2017 an adaptive algorithm...
Pharma companies are as excited as anyone about the shift to value-based care and the ways that technology can enable it, but they’re increasingly skeptical about the speed of that change. At Health 2.0 this week in Santa Clara, California, at a panel moderated by Kian Beyzavi, principal investor at KBeyzavi and Associates, several innovation executives at pharmaceuticals talked about value-based...
Digital medicine company Akili Interactive Labs announced an $11.9 million expansion of its recent Series B funding, adding new investors into the round and bringing the series total to $42.4 million.
The Dutch subsidiary of Merck Ventures, known as M Ventures in the US and Canada, and the venture arm of Amgen joined existing investors, which include Pfizer and Shire Pharmaceuticals. This means...
